ilovemoney29 wrote a post · Dec 29, 2022 16:38

Long Term Pharma Holds

Pharma industry has been doing well despite the recession, and I believe these companies will continue to do well moving forward (they have upcoming catalysts in q1/h1 2023)

1. $Viking Therapeutics (VKTX.US)$ closest competitor to $Madrigal Pharmaceuticals (MDGL.US)$ , which recently announced breakthroughs in the NASH space and price went up ×4 times. multiple catalysts in 2023 q1.

2. $ProQR Therapeutics (PRQR.US)$ announced collaboration with LLY, their RNAI editing software is very novel and seems to be patented. LLY collaboration will help expedite its research, might be a future buyout canditate. Now might be too early to say, but in a few months time (when they announce their pipeline) or even years (looking at 2-3 years horizon) if all goes well this may hit 50++.

3. $PDS Biotechnology (PDSB.US)$ sole license to itself, whereas large caps like $Moderna (MRNA.US)$ dun even have.

Other mentions: $89bio (ETNB.US)$ (nash industry), $Akero Therapeutics (AKRO.US)$ (nash industry, price dropped in dec over safety concerns), $Beam Therapeutics (BEAM.US)$ (hyped technology, will be interesting if can sustain the hype).

If your have other recommendations for biopharma pls add here also and Ill take a look. Hit me up if you want to talk about biopharma too

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

Translate

Report

107K Views

Comment

mrittika1971 : @ilovemoney29 what about $HeartSciences (HSCS.US)$ $Verastem (VSTM.US)$ $Scynexis (SCYX.US)$ $LumiraDx (LMDX.US)$ $InMed Pharmaceuticals (INM.US)$ $NRX Pharmaceuticals (NRXP.US)$ $Tracon Pharmaceuticals (Delisted) (TCON.US)$????

Report
Reply

Cancel Reply

ilovemoney29

seeks out hidden stocks with high potential, loves spacs. chat with me about anything related to spacs

390

Followers

Following

1983

Visitors